Loading clinical trials...
Loading clinical trials...
The aim of this study is to assess whether increasing oral doses of Riociguat are safe and improve the well-being, symptoms and outcome in patients with pulmonary hypertension associated with left ven...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Bayer
NCT06814145 · Hypertension, Pulmonary
NCT07079592 · Artificial Intelligence (AI), Artificial Intelligence (AI) in Diagnosis, and more
NCT05719415 · Hypertension, Pulmonary, Pulmonary Thromboembolisms
NCT01501838 · Hypertension, Pulmonary Arterial
NCT07039604 · Pulmonary Hypertension, Hypertension, Pulmonary Arterial
Los Angeles, California
San Diego, California
Torrance, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions